Awakn Life Sciences Archives

Psychedelics News

Awakn Life Sciences

Don’t Miss

5 Jul 2022

News You Might Have Missed: July 5th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Industry

17 Jun 2022

Top Clinical Trials in 2022 (Part 2)

The success or failure of the sector’s advanced clinical trials will dictate the future of the industry....

By Jason Najum

Don’t Miss

6 Jun 2022

News You Might Have Missed: June 6th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Industry

20 May 2022

Awakn Life Sciences Completes New Study for Addiction

Awakn Life Science has announced positive results from a new study that uses ketamine for a range of addiction disorders....

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

17 Mar 2022

Awakn Life Sciences Announces New Clinic: A Closer Look

With two advanced Phase 2 studies underway (using both ketamine and MDMA for alcohol addiction) Awakn has quietly put itself in the top tier of companies in terms of clinical...

By Jason Najum

Industry

15 Mar 2022

Is the UK Becoming a Global Center for Psychedelic Medicine?

With innovative companies and industry-leading research, as well as an increasingly favorable regulatory environment, it seems the United Kingdom is indeed positioning itself as a leading center for the psychedelic...

By Freddie Earlam

Industry

19 Jan 2022

Awakn Life Sciences Signs MOU With MAPS

Agreement to explore a partnership for MDMA-Assisted Therapy for treatment of Alcohol Use Disorder in Europe...

By Microdose

Breaking News

11 Jan 2022

Awakn Announces Positive Results from Phase II Trial of Alcohol Use Disorder

Primary and Secondary Endpoints Achieved, Including 86% Abstinence Over 6 Months Post Treatment and No Serious Adverse Events...

By Microdose

Events

25 Oct 2021

Microdose Announces Awakn Life Sciences as Wonderland Business Lounge Sponsor

Microdose Announces Awakn Life Sciences as Wonderland Business Lounge Sponsor...

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result